The Canonsburg, Pa.-based drugmaker recalled four lots of amiodarone HCl injection, which treats heart rhythm issues, and tranexamic acid injection, which promotes blood clotting.
Both medications are administered by healthcare professionals in hospital or clinic settings. Mylan is notifying its wholesalers and hospital pharmacies of the recall by letter.
The drugmaker has not received any reports of adverse events.
More articles on pharmacy:
FDA extends remdesivir’s emergency use authorization to all hospitalized COVID-19 patients
Walgreens names former Rite Aid CEO as its new president
78% of Americans think vaccine approval process is too politics-driven
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
